Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (241-250 of 311) with videos related to

Pageof 32
Sort By:
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Journal of Autoimmunity|April 22, 2018
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patientsArsene Mekinian, Mathieu Resche-Rigon, Cloé Comarmond, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's diseaseCheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.
Joint Bone Spine|July 14, 2025
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseasesJérôme Avouac, Olivier Fogel, Maxime Beydon, et al.
Advances in Therapy|December 16, 2024
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised IndividualsChristoph D Spinner, Samira Bell, Hermann Einsele, et al.
Human Vaccines & Immunotherapeutics|May 5, 2026
Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trialsFaye Yu, Eugene Myshkin, Brandon Nguyen, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|February 25, 2011
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|November 2, 2019
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesManuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, et al.
RMD Open|November 8, 2018
Sjögren's syndrome: state of the art on clinical practice guidelinesVasco C Romão, Rosaria Talarico, Carlo Alberto Scirè, et al.
Pageof 32

Showing results (241-250 of 311) with videos related to

Sort By:
Pageof 32
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Journal of Autoimmunity|April 22, 2018
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patientsArsene Mekinian, Mathieu Resche-Rigon, Cloé Comarmond, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's diseaseCheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.
Joint Bone Spine|July 14, 2025
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseasesJérôme Avouac, Olivier Fogel, Maxime Beydon, et al.
Advances in Therapy|December 16, 2024
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised IndividualsChristoph D Spinner, Samira Bell, Hermann Einsele, et al.
Human Vaccines & Immunotherapeutics|May 5, 2026
Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trialsFaye Yu, Eugene Myshkin, Brandon Nguyen, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|February 25, 2011
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|November 2, 2019
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesManuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, et al.
RMD Open|November 8, 2018
Sjögren's syndrome: state of the art on clinical practice guidelinesVasco C Romão, Rosaria Talarico, Carlo Alberto Scirè, et al.
Pageof 32